Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab

E. Buonamico, S. Dragonieri, P. I. Sciancalepore, P. Carratù, G. E. Carpagnano, O. Resta, M. Gelardi

PDF(466 KB)
Journal of Biological Regulators and Homeostatic Agents ›› 2020, Vol. 34 ›› Issue (6) : 2353-2357. DOI: 10.23812/20-323-L
Letter

Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 34(6): 2353-2357 https://doi.org/10.23812/20-323-L

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
Article Options
  • PDF (167 views)
  • Full Text ( views)

Accesses

Citation

Detail

Sections
Recommended

/